Literature DB >> 30077757

Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.

Michael P Whyte1, S Deepak Amalnath2, William H McAlister3, Radhakrishna Pedapati4, Vivekanandan Muthupillai5, Shenghui Duan6, Margaret Huskey7, Vinieth N Bijanki8, Steven Mumm9.   

Abstract

Sclerosteosis (SOST) refers to two extremely rare yet similar skeletal dysplasias featuring a diffusely radiodense skeleton together with congenital syndactyly. SOST1 is transmitted as an autosomal recessive (AR) trait and to date caused by ten homozygous loss-of-function mutations within the gene SOST that encodes the inhibitor of Wnt-mediated bone formation, sclerostin. SOST2 is transmitted as an autosomal dominant (AD) or AR trait and to date caused by one heterozygous or two homozygous loss-of-function mutation(s), respectively, within the gene LRP4 that encodes the sclerostin interaction protein, low-density lipoprotein receptor-related protein 4 (LRP4). Herein, we investigated two teenagers and one middle-aged man with SOST in three families living in the state of Tamil Nadu in southern India. Next generation sequencing of their genomic DNA using our high bone density gene panel revealed SOST1 in the teenagers caused by a unique homozygous nonsense SOST mutation (c.129C > G, p.Tyr43X) and SOST2 in the man caused by homozygosity for one of the two known homozygous missense LRP4 mutations (c.3508C > T, p.Arg1170Trp). He becomes the fourth individual and the first non-European recognized with SOST2. His clinical course was milder than the life-threatening SOST1 demonstrated by the teenagers who suffered blindness, deafness, and raised intracranial pressure, yet his congenital syndactyly was more striking by featuring bony fusion of digits. All three patients were from consanguineous families and heterozygosity for the SOST mutation was documented in the mothers of both teenagers. Thus, on the endogamous genetic background of Indian Tamils, SOST1 from sclerostin deficiency compared to SOST2 from LRP4 deactivation is a more severe and life-threatening disorder featuring complications due to osteosclerosis of especially the skull. In contrast, the syndactyly of SOST2 is particularly striking by involving bony fusion of some digits. Both the SOST and LRP4 mutations in this ethnic population likely reflect genetic founders.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blindness; Consanguinity; DXA; Deafness; Embryogenesis; Hyperostosis; Hyperphosphatasemia; LRP4; Osteoblast; Osteopetrosis; Osteosclerosis; SOST; Sclerostin; Syndactyly; Wnt signaling

Mesh:

Substances:

Year:  2018        PMID: 30077757     DOI: 10.1016/j.bone.2018.07.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

Review 1.  Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.

Authors:  Lucia Oton-Gonzalez; Chiara Mazziotta; Maria Rosa Iaquinta; Elisa Mazzoni; Riccardo Nocini; Lorenzo Trevisiol; Antonio D'Agostino; Mauro Tognon; John Charles Rotondo; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

2.  A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.

Authors:  Aishah A Ekhzaimy; Ebtihal Y Alyusuf; Meshael Alswailem; Ali S Alzahrani
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

Review 3.  Genetic approaches to metabolic bone diseases.

Authors:  Fadil M Hannan; Paul J Newey; Michael P Whyte; Rajesh V Thakker
Journal:  Br J Clin Pharmacol       Date:  2018-11-28       Impact factor: 4.335

Review 4.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

5.  Identification of Compound Heterozygous Variants in LRP4 Demonstrates That a Pathogenic Variant outside the Third β-Propeller Domain Can Cause Sclerosteosis.

Authors:  Yentl Huybrechts; Eveline Boudin; Gretl Hendrickx; Ellen Steenackers; Neveen Hamdy; Geert Mortier; Guillermo Martínez Díaz-Guerra; Milagros Sierra Bracamonte; Natasha M Appelman-Dijkstra; Wim Van Hul
Journal:  Genes (Basel)       Date:  2021-12-28       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.